Cognition Disorders

• 

  Subject Areas on Research

  • A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. 
  • A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. 
  • A U-shaped Association Between Blood Pressure and Cognitive Impairment in Chinese Elderly. 
  • A brief assessment of learning for orphaned and abandoned children in low and middle income countries. 
  • A case of frontal neuropsychological and neuroimaging signs following multiple primary-blast exposure. 
  • A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial. 
  • A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. 
  • A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. 
  • A longitudinal study of neurocognitive function in individuals at-risk for psychosis. 
  • A low-vision rehabilitation program for patients with mild cognitive deficits. 
  • A multiplicity of approaches to characterize geriatric depression and its outcomes. 
  • A pilot cluster-randomized trial of a 20-week Tai Chi program in elders with cognitive impairment and osteoarthritic knee: effects on pain and other health outcomes. 
  • A pilot study evaluating presurgery neuroanatomical biomarkers for postoperative cognitive decline after total knee arthroplasty in older adults. 
  • A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. 
  • A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus. 
  • A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. 
  • A prospective study of the relationship over time of behavior problems, intellectual functioning, and family functioning in children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. 
  • A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. 
  • A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. 
  • A rat model of the cognitive impairment from Pfiesteria piscicida exposure. 
  • A review on the management of epilepsy associated with hypothalamic hamartomas. 
  • A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. 
  • A supplemental report to a randomized cluster trial of a 20-week Sun-style Tai Chi for osteoarthritic knee pain in elders with cognitive impairment. 
  • A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. 
  • A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression. 
  • APOE epsilon4 allele carriers: Biological, psychological, and social variables associated with cognitive impairment. 
  • Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcome. 
  • Acute neuropsychological functioning following cardiosurgical interventions associated with the production of intraoperative cerebral microemboli. 
  • Adult age differences in the use of distractor homogeneity during visual search. 
  • Adult age differences in visual word identification: functional neuroanatomy by positron emission tomography. 
  • Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease. 
  • Advancing Symptom Science Through Use of Common Data Elements. 
  • Aerobic exercise and neurocognitive performance: A meta-analytic review of randomized controlled trials 
  • Age differences in symptom expression in patients with major depression. 
  • Age effects of coronary artery bypass graft on cognitive status change among elderly male twins. 
  • Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. 
  • Aging and cancer. 
  • Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. 
  • Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. 
  • Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. 
  • Alzheimer’s disease: the new promise. 
  • Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease. 
  • Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease. 
  • Amyloid-associated depression: a prodromal depression of Alzheimer disease? 
  • Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. 
  • Amyotrophic lateral sclerosis: current practice and future treatments. 
  • An assessment by the Statin Cognitive Safety Task Force: 2014 update. 
  • Ankle-brachial index, cognitive impairment and cerebrovascular disease in a Chinese population. 
  • Anticholinergic drugs and elderly people: a no brainer? 
  • Anticipating DSM-V: opportunities and challenges for cognition and psychosis. 
  • Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. 
  • Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. 
  • Antipsychotic drug effects on brain morphology in first-episode psychosis. 
  • Aortic atheroma burden and cognitive dysfunction after coronary artery bypass graft surgery. 
  • Apolipoprotein E and cognitive decline in Alzheimer's disease. 
  • Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. 
  • Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. 
  • Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults. 
  • Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study. 
  • Appetite loss and neurocognitive deficits in late-life depression. 
  • Applications of TMS to therapy in psychiatry. 
  • Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. 
  • Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity? 
  • Are effort measures sensitive to cognitive impairment? 
  • Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. 
  • Arterial hyperoxia during cardiopulmonary bypass and postoperative cognitive dysfunction. 
  • Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion). 
  • Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help? 
  • Assessment of the interaction of hyperbaric N2, CO2, and O2 on psychomotor performance in divers. 
  • Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. 
  • Association Between Oral Health and Cognitive Status: A Systematic Review. 
  • Association between C-reactive protein and cognitive deficits in elderly men and women: a meta-analysis. 
  • Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. 
  • Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. 
  • Association of Childhood Blood Lead Levels With Cognitive Function and Socioeconomic Status at Age 38 Years and With IQ Change and Socioeconomic Mobility Between Childhood and Adulthood. 
  • Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients. 
  • Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age. 
  • Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. 
  • Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly. 
  • Association of poor physical function and cognitive dysfunction with high nocturnal blood pressure level in treated elderly hypertensive patients. 
  • Association of vascular health and neurocognitive performance in overweight adults with high blood pressure. 
  • Associations between Benzodiazepine Use and Neuropsychological Test Scores in Older Adults. 
  • Associations between child disabilities and caregiver discipline and violence in low- and middle-income countries. 
  • Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke. 
  • Associations of Nocturnal Blood Pressure With Cognition by Self-Identified Race in Middle-Aged and Older Adults: The GENOA (Genetic Epidemiology Network of Arteriopathy) Study. 
  • Associations of job demands and intelligence with cognitive performance among men in late life. 
  • Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. 
  • Autism as a disorder of neural information processing: directions for research and targets for therapy. 
  • Autoimmunity to munc-18 in Rasmussen's encephalitis. 
  • Bartonella sp. bacteremia in patients with neurological and neurocognitive dysfunction. 
  • Baseline disability in activities of daily living predicts dementia risk even after controlling for baseline global cognitive ability and depressive symptoms. 
  • Baseline neurocognitive deficits in the CATIE schizophrenia trial. 
  • Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. 
  • Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. 
  • Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. 
  • Biologic findings of post-traumatic stress disorder and child maltreatment. 
  • Biological and social predictors of long-term geriatric depression outcome. 
  • Blood Pressure Reactivity to Psychological Stress in Young Adults and Cognition in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. 
  • Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure. 
  • Brain Gaming: A User's Product Guide for the Clinician. 
  • Brain atrophy and cognitive deficits in Cushing's disease. 
  • Brain connectivity and visual attention. 
  • Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. 
  • Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. 
  • Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. 
  • Brominated flame retardants in breast milk and behavioural and cognitive development at 36 months. 
  • COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain. 
  • COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat. 
  • COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome. 
  • Callous/unemotional traits and social-cognitive processes in adjudicated youths. 
  • Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. 
  • Cardiopulmonary bypass and the central nervous system: potential for cerebral protection. 
  • Cardiopulmonary bypass induces neurologic and neurocognitive dysfunction in the rat. 
  • Cardiorespiratory fitness and cognitive function in midlife: neuroprotection or neuroselection? 
  • Caring for individuals with dementia and cognitive impairment, not dementia: findings from the aging, demographics, and memory study. 
  • Central nervous system injury associated with cardiac surgery. 
  • Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. 
  • Cerebral microbleeds and cognition: the epidemiology of dementia in Singapore study. 
  • Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort. 
  • Cerebral white matter integrity and cognitive aging: contributions from diffusion tensor imaging. 
  • Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. 
  • Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. 
  • Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease. 
  • Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. 
  • Change in plasma glutamate concentration during cardiac surgery is a poor predictor of cognitive outcome. 
  • Change in stress and social support as predictors of cognitive decline in older adults with and without depression. 
  • Changes in brain function occur years before the onset of cognitive impairment. 
  • Changes of Health Status and Institutionalization Among Older Adults in China. 
  • Characteristics associated with presence of depressive symptoms in adults with autism spectrum disorder. 
  • Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. 
  • Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. 
  • Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. 
  • Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge. 
  • Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. 
  • Chronic pain-associated behaviors in the nursing home: resident versus caregiver perceptions. 
  • Circadian rhythms in cognitive functioning among patients with schizophrenia: impact on signal detection in clinical trials of potential pro-cognitive therapies. 
  • Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. 
  • Classification of neurocognitive disorders in DSM-5: a work in progress. 
  • Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. 
  • Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. 
  • Clinical trials in children with Down syndrome: issues from a cognitive research perspective. 
  • Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? 
  • Cognition in schizophrenia: summary Nice Consultation Meeting 2012. 
  • Cognitive Aging: What We Fear and What We Know. 
  • Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience study. 
  • Cognitive and Behavioral Impairments Evoked by Low-Level Exposure to Tobacco Smoke Components: Comparison with Nicotine Alone. 
  • Cognitive and behavioral anomalies among insomnia patients with mixed restless legs and periodic limb movement disorder. 
  • Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. 
  • Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. 
  • Cognitive aspects of chronic depression. 
  • Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: a randomized controlled trial. 
  • Cognitive burden of anticholinergic medications in psychotic disorders. 
  • Cognitive control in mild traumatic brain injury: conflict monitoring and conflict adaptation. 
  • Cognitive decline after major noncardiac operations: a preliminary prospective study. 
  • Cognitive decline in the elderly: an analysis of population heterogeneity. 
  • Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. 
  • Cognitive deficits and CNS damage after a 4-day binge ethanol exposure in rats. 
  • Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. 
  • Cognitive deficits in patients with schizophrenia: effects and treatment. 
  • Cognitive distortions among depressed and suicidal drug abusers. 
  • Cognitive dysfunction after cardiac surgery: revisiting etiology. 
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. 
  • Cognitive effects of nicotine. 
  • Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. 
  • Cognitive estrangement, science fiction, and medical ethics. 
  • Cognitive function and acute care utilization. 
  • Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. 
  • Cognitive function and dental care utilization among community-dwelling older adults. 
  • Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study. 
  • Cognitive function, physical performance, health, and disease: norms from the georgia centenarian study. 
  • Cognitive functioning in Alzheimer's and vascular dementia: a meta-analysis. 
  • Cognitive functioning throughout the treatment history of clinical late-life depression. 
  • Cognitive impairment and depression outcomes in the IMPACT study. 
  • Cognitive impairment and mortality among nonagenarians: the Danish 1905 cohort survey. 
  • Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: findings from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry. 
  • Cognitive impairment in schizophrenia. 
  • Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. 
  • Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). 
  • Cognitive measures of adolescent depression: unique or unitary constructs? 
  • Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. 
  • Cognitive outcomes analyses: two steps forward, one step back? 
  • Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. 
  • Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of education. 
  • Cognitive sequelae of blast-related versus other mechanisms of brain trauma. 
  • Cognitive subdomain responses to galantamine in Alzheimer's disease. 
  • Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. 
  • Comment on: The Mini-Mental State Exam (MMSE) is not sensitive to cognitive impairment in bariatric surgery candidates. 
  • Comment on: cognitive function predicts weight loss following bariatric surgery. 
  • Comorbid cognitive impairment and functional trajectories in low vision rehabilitation for macular disease. 
  • Comorbid visual and cognitive impairment: relationship with disability status and self-rated health among older Singaporeans. 
  • Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. 
  • Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. 
  • Comparison of methods for analyzing longitudinal binary outcomes: cognitive status as an example. 
  • Comparison of neuropsychological profiles in patients with Alzheimer's disease and mixed dementia. 
  • Competing risk of household expansion or institutionalization in late life. 
  • Complex relationships of nicotinic receptor actions and cognitive functions. 
  • Comprehensive care of the elderly patient with cancer. 
  • Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis. 
  • Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. 
  • Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB). 
  • Contextual social-cognitive mediators and child outcome: a test of the theoretical model in the Coping Power program. 
  • Contribution of depression to cognitive impairment and dementia in older adults. 
  • Conversion to dementia from mild cognitive disorder: the Cache County Study. 
  • Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions. 
  • Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. 
  • Cortical activity differs during nicotine deprivation versus satiation in heavy smokers. 
  • Cortical cerebral microinfarcts on 3T MRI: A novel marker of cerebrovascular disease. 
  • Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. 
  • Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. 
  • Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. 
  • Current and future treatments for cognitive deficits in dementia. 
  • Day of injury CT and late MRI findings: Cognitive outcome in a paediatric sample with complicated mild traumatic brain injury. 
  • Declines Noted in Cognitive Processes and Association With Achievement Among Children With Leukemia. 
  • Declining prevalence of dementia in the U.S. elderly population. 
  • Decreased cognitive function in extended family members from the single late-onset-Alzheimer's-disease pedigree. 
  • Default mode network connectivity in stable vs progressive mild cognitive impairment. 
  • Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction. 
  • Defining a cognitive function decrement in schizophrenia. 
  • Defining dysfunction: group means versus incidence analysis--a statement of consensus. 
  • Defining meaningful change in Alzheimer's disease trials: the donepezil experience. 
  • Defining neuropsychological dysfunction after coronary artery bypass grafting. 
  • Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. 
  • Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment. 
  • Dental care utilization among older adults with cognitive impairment in the USA. 
  • Depressed adolescents and comorbid psychiatric disorders: are there differences in the presentation of depression? 
  • Depression and cognition in the elderly. 
  • Depression in elderly hospitalized patients with medical illness. 
  • Depressive Symptoms Increase the Risk of Mild Neurocognitive Disorders among Elderly Chinese. 
  • Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression. 
  • Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults. 
  • Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. 
  • Development of Response Evaluation and Decision (RED) and antisocial behavior in childhood and adolescence. 
  • Development of nicotinic drug therapy for cognitive disorders. 
  • Development of treatments for toxicant-induced cognitive deficits. 
  • Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. 
  • Developmental outcome of very low birth weight infants as a function of biological risk and psychosocial risk. 
  • Deviation from expected cognitive ability across psychotic disorders. 
  • Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. 
  • Diet and neurocognition: review of evidence and methodological considerations. 
  • Dietary Patterns Associated with Cognitive Function among the Older People in Underdeveloped Regions: Finding from the NCDFaC Study. 
  • Dietary Patterns and Cognitive Decline Among Chinese Older Adults. 
  • Differential age effects of mean arterial pressure and rewarming on cognitive dysfunction after cardiac surgery. 
  • Differential age-related decline in conflict-driven task-set shielding from emotional versus non-emotional distracters. 
  • Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. 
  • Differential item functioning due to cognitive status does not impact depressive symptom measures in four heterogeneous samples of older adults. 
  • Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. 
  • Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. 
  • Diffusion tensor imaging: background, potential, and utility in psychiatric research. 
  • Disability but not social support predicts cognitive deterioration in late-life depression. 
  • Disability in geriatric depression. 
  • Disparities among older adults in measures of cognitive function by race or ethnicity. 
  • Disparities in pain management between cognitively intact and cognitively impaired nursing home residents. 
  • Disruption of Fgf13 causes synaptic excitatory-inhibitory imbalance and genetic epilepsy and febrile seizures plus. 
  • Divergent trajectories in the aging mind: changes in working memory for affective versus visual information with age. 
  • Do nutrition indicators predict death in elderly Canadians with cognitive impairment? 
  • Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. 
  • Does antidepressant therapy improve cognition in elderly depressed patients? 
  • Does assistive technology substitute for personal assistance among the disabled elderly? 
  • Does epileptiform activity contribute to cognitive impairment in Alzheimer's disease? 
  • Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? 
  • Does maternal warmth moderate the effects of birth weight on twins' attention-deficit/hyperactivity disorder (ADHD) symptoms and low IQ? 
  • Domestic violence is associated with environmental suppression of IQ in young children. 
  • Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial. 
  • Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17. 
  • Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design. 
  • Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. 
  • Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction. 
  • Down Syndrome Disintegrative Disorder: New-Onset Autistic Regression, Dementia, and Insomnia in Older Children and Adolescents With Down Syndrome. 
  • Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry. 
  • Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. 
  • Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. 
  • Early language development in children exposed to or infected with human immunodeficiency virus. 
  • Early postnatal parathion exposure in rats causes sex-selective cognitive impairment and neurotransmitter defects which emerge in aging. 
  • Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? 
  • Early social, imitation, play, and language abilities of young non-autistic siblings of children with autism. 
  • Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. 
  • Effect of APOE and CD33 on Cognitive Decline. 
  • Effect of a clinical stroke on the risk of dementia in a prospective cohort. 
  • Effect of aging on cerebral autoregulation during cardiopulmonary bypass. Association with postoperative cognitive dysfunction. 
  • Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. 
  • Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. 
  • Effects of Acute, Profound Hypoxia on Healthy Humans: Implications for Safety of Tests Evaluating Pulse Oximetry or Tissue Oximetry Performance. 
  • Effects of Single Low Dose of Dexamethasone before Noncardiac and Nonneurologic Surgery and General Anesthesia on Postoperative Cognitive Dysfunction-A Phase III Double Blind, Randomized Clinical Trial. 
  • Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. 
  • Effects of cognitive performance on change in physical function in long-stay nursing home residents. 
  • Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging. 
  • Effects of education and race on cognitive decline: An integrative study of generalizability versus study-specific results. 
  • Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. 
  • Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. 
  • Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials. 
  • Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. 
  • Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. 
  • Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. 
  • Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. 
  • Electroconvulsive therapy does not damage the brain. 
  • Emerging pharmacotherapy for cancer patients with cognitive dysfunction. 
  • Emotional curiosity: modulation of visuospatial attention by arousal is preserved in aging and early-stage Alzheimer's disease. 
  • Enriched white matter connectivity networks for accurate identification of MCI patients. 
  • Epidemiology of apathy in older adults: the Cache County Study. 
  • Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. 
  • Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging. 
  • Epidemiology of drug-disease interactions in older veteran nursing home residents. 
  • Equivalence of two screens of cognitive functioning: the Short Portable Mental Status Questionnaire and the Orientation-Memory-Concentration test. 
  • Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. 
  • Ethnic differences among adolescents beginning treatment for depression. 
  • Ethnically diverse older adults' beliefs about staying mentally sharp. 
  • Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease. 
  • Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory. 
  • Evidence for latent classes of IQ in young children with autism spectrum disorder. 
  • Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. 
  • Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. 
  • Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. 
  • Executive function and depression as independent risk factors for postoperative delirium. 
  • Executive function deficits in acute stroke. 
  • Executive functioning and central coherence in anorexia nervosa: Pilot investigation of a neurocognitive endophenotype. 
  • Executive functioning early in abstinence from alcohol. 
  • Exercise fails to improve neurocognition in depressed middle-aged and older adults. 
  • Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. 
  • Extracellular superoxide dismutase (EC-SOD) quenches free radicals and attenuates age-related cognitive decline: opportunities for novel drug development in aging. 
  • Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. 
  • Facioscapulohumeral muscular dystrophy can be a cause of isolated childhood cognitive dysfunction. 
  • Factor analysis and validity of the Conners Parent and Teacher Rating Scales in childhood cancer survivors. 
  • Factors associated with cognitive evaluations in the United States. 
  • Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. 
  • Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia. 
  • Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life. 
  • Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. 
  • Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. 
  • Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. 
  • Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. 
  • Fish intake is associated with slower cognitive decline in Chinese older adults. 
  • Fixing the heart: must the brain pay the price? 
  • Food Insecurity Is Associated with Cognitive Deficits Among HIV-Positive, But Not HIV-Negative, Individuals in a United States Sample. 
  • Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. 
  • From the bridges of Konigsberg to the fields of Alzheimer: connecting the dots. 
  • Frontal lobe trauma in the elderly. Personality changes aren't always dementia. 
  • Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. 
  • Functional connectivity: a source of variance in the association between cardiorespiratory fitness and cognition? 
  • Functional magnetic resonance imaging of autism spectrum disorders. 
  • Functional outcomes in schizophrenia. 
  • Generativity abilities predict communication deficits but not repetitive behaviors in Autism Spectrum Disorders. 
  • Genetic and environmental correlates of topiramate-induced cognitive impairment. 
  • Genetic and environmental processes in young children's resilience and vulnerability to socioeconomic deprivation. 
  • Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors. 
  • Genetic influences on cerebral outcome after cardiac surgery. 
  • Genetic influences on the overlap between low IQ and antisocial behavior in young children. 
  • Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. 
  • Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 
  • Geriatric depression and cognitive impairment. 
  • Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. 
  • Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia. 
  • Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection. 
  • Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects. 
  • Guest editorial: Cognitive-communication rehabilitation for combat-related mild traumatic brain injury. 
  • Guilty by association?*. 
  • GxE interactions between FOXO genotypes and drinking tea are significantly associated with prevention of cognitive decline in advanced age in China. 
  • HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3. 
  • Heritability of functioning in families with schizophrenia in relation to neurocognition. 
  • Hierarchical cognitive control deficits following damage to the human frontal lobe. 
  • Hierarchical temporal processing deficit model of reality distortion and psychoses. 
  • High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. 
  • Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment. 
  • Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. 
  • Hippocampal volume and the Mini-Mental State Examination in the diagnosis of amnestic mild cognitive impairment. 
  • Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression. 
  • Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. 
  • Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study. 
  • How should DSM-V criteria for schizophrenia include cognitive impairment? 
  • Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. 
  • Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma. 
  • Hypercapnia in diving: a review of CO₂ retention in submersed exercise at depth. 
  • Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. 
  • Impact of APOE in mild cognitive impairment. 
  • Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. 
  • Impact of anemia on mortality, cognition, and function in community-dwelling elderly. 
  • Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. 
  • Impact of offspring death on cognitive health in late life: the Cache County study. 
  • Impaired neurocognitive functions affect social learning processes in oppositional defiant disorder and conduct disorder: implications for interventions. 
  • Improving post-intensive care unit neuropsychiatric outcomes: understanding cognitive effects of physical activity. 
  • Impulsive and premeditated subtypes of aggression in conduct disorder: differences in time estimation. 
  • Incidence of dementia and cognitive impairment, not dementia in the United States. 
  • Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. 
  • Independent association of cognitive dysfunction with cardiac hypertrophy irrespective of 24-h or sleep blood pressure in older hypertensives. 
  • Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. 
  • Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment. 
  • Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. 
  • Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia. 
  • Insight in first-episode psychosis. 
  • Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. 
  • Interventions for mild cognitive impairment and Alzheimer disease: new strategies, new hope. 
  • Intracranial stenosis, cerebrovascular diseases, and cognitive impairment in chinese. 
  • Intraoperative hyperglycemia and cognitive decline after CABG. 
  • Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. 
  • Intravascular malignant lymphomatosis with neurologic presentation: factors facilitating antemortem diagnosis. 
  • Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA). 
  • Is antioxidant use protective of cognitive function in the community-dwelling elderly? 
  • Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study. 
  • Is insomnia associated with deficits in neuropsychological functioning? Evidence from a population-based study. 
  • Is stroke history reliably reported by elderly with cognitive impairment? A community-based study. 
  • Is the prefrontal cortex necessary for delay task performance? Evidence from lesion and FMRI data. 
  • Is there a multiplicative adverse effect of cardiovascular and kidney disease on neuropsychological measures? 
  • J'accuse! depression as a likely culprit in cases of AD. 
  • Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. 
  • Lateralized brain dysfunction in autism: evidence from the Halstead-Reitan neuropsychological battery. 
  • Learning and memory in combat veterans with posttraumatic stress disorder. 
  • Lifespan influences on mid- to late-life cognitive function in a Chinese birth cohort. 
  • Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. 
  • Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. 
  • Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women. 
  • Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. 
  • Long-term metformin usage and cognitive function among older adults with diabetes. 
  • Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. 
  • Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. 
  • Longitudinal assessment of neurocognitive function in rats after cardiopulmonary bypass: evidence for long-term deficits. 
  • Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalus. 
  • Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. 
  • Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. 
  • Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia. 
  • Measures of executive function and depression identify patients at risk for postoperative delirium. 
  • Medication misadventures in older adults: literature from 2013. 
  • Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. 
  • Melancholia in later life: late and early onset differences in presentation, course, and dementia risk. 
  • Memory complaint as a predictor of cognitive decline: a comparison of African American and White elders. 
  • Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations. 
  • Mercury-induced cognitive impairment in metallothionein-1/2 null mice. 
  • Methodological issues in negative symptom trials. 
  • Methodological issues in the assessment of neuropsychologic function after cardiac surgery. 
  • Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study. 
  • Methods for delivering and evaluating the efficacy of cognitive enhancement. 
  • Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. 
  • Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. 
  • Mild cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiologic Studies of the Elderly cohort. 
  • Mild cognitive impairment: evaluation with 4-T functional MR imaging. 
  • Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine. 
  • More evidence for the benefits of cognitive activity over the lifespan. 
  • Motor cortex stimulation and neuropathic facial pain. 
  • Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression. 
  • Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. 
  • Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. 
  • Myopia and cognitive dysfunction: the singapore malay eye study. 
  • Myotonic dystrophy. 
  • Neural correlates associated with cognitive decline in late-life depression. 
  • Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans. 
  • Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model. 
  • Neurocognitive and electrophysiological evidence of altered face processing in parents of children with autism: implications for a model of abnormal development of social brain circuitry in autism. 
  • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. 
  • Neurocognitive changes after lung transplantation. 
  • Neurocognitive correlates of response to treatment in late-life depression. 
  • Neurocognitive development of young children with sickle cell disease through three years of age. 
  • Neurocognitive disorders in DSM-5. 
  • Neurocognitive dysfunction following cardiac surgery. 
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. 
  • Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. 
  • Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. 
  • Neurocognitive impairment in children and adolescents with systemic lupus erythematosus. 
  • Neurocognitive impairments in boys on the life-course persistent antisocial path. 
  • Neurocognitive outcomes after cardiac surgery. 
  • Neurocognitive outcomes after extracorporeal membrane oxygenation. 
  • Neurocognitive testing and functioning in adults sickle cell disease. 
  • Neurodevelopmental delays in children with deformational plagiocephaly. 
  • Neuroimaging correlates of dementia rating scale performance at baseline and 12-month follow-up among patients with vascular dementia. 
  • Neurologic outcomes after coronary artery bypass grafting with and without cardiopulmonary bypass. 
  • Neurologic risk assessment, monitoring and outcome in cardiac surgery. 
  • Neurological injury after transcatheter aortic valve implantation: are the trees falling silently or is our hearing impaired? 
  • Neuronal activity-regulated gene transcription in synapse development and cognitive function. 
  • Neuronal hypertrophy in asymptomatic Alzheimer disease. 
  • Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. 
  • Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. 
  • Neuropsychiatric Issues in Parkinson's Disease. 
  • Neuropsychiatric complications after temporal lobe limbic system surgery. 
  • Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. 
  • Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. 
  • Neuropsychological aspects of disorientation. 
  • Neuropsychological correlates of early symptoms of autism. 
  • Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. 
  • Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. 
  • Neuropsychological findings in childhood neglect and their relationships to pediatric PTSD. 
  • Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. 
  • Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. 
  • Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. 
  • Neuropsychological predictors of dementia in late-life major depressive disorder. 
  • Neuropsychological profile in adult schizophrenia measured with the CMINDS. 
  • Neuropsychological sequelae of PTSD and TBI following war deployment among OEF/OIF veterans. 
  • Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. 
  • Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. 
  • Nicotinic systems and cognitive function. 
  • Nicotinic treatment for cognitive dysfunction. 
  • Nocturnal heart rate and cerebrovascular disease. 
  • Norms for CERAD constructional praxis recall. 
  • Obstructive sleep apnea and delirium: exploring possible mechanisms. 
  • Older person behavioral and psychological symptoms (BPS) and functional limitations mediate the association between older person cognitive impairment and depressive symptoms in the caregiver. 
  • One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. 
  • Open heart surgery and cognitive decline. 
  • Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. 
  • Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. 
  • Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. 
  • PC-FACS. 
  • PET scanning in mild cognitive impairment. 
  • Parent education and biologic factors influence on cognition in sickle cell anemia. 
  • Parental education and late-life dementia in the United States. 
  • Participants in the Program of All-Inclusive Care for the Elderly (PACE) demonstration: developing disease-impairment-disability profiles. 
  • Pathophysiological distortions in time perception and timed performance. 
  • Patient preferences for stroke outcomes. 
  • Perceived social competency in children with brain tumors: comparison between children on and off therapy. 
  • Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus. 
  • Perception of cognitive function in older adults following coronary artery bypass surgery. 
  • Perception of unmet basic needs as a predictor of depressive symptoms among community-dwelling older adults. 
  • Performance monitoring and cognitive control in individuals with mild traumatic brain injury. 
  • Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery. 
  • Performance of recently detoxified patients with alcoholism on a neuropsychological screening test. 
  • Perinatal factors associated with poor neurocognitive outcome in early school age congenital diaphragmatic hernia survivors. 
  • Perioperative cognitive decline in the aging population. 
  • Perioperative neurotoxicity in the elderly: summary of the 4th International Workshop. 
  • Persistent cognitive alterations in rats after early postnatal exposure to low doses of the organophosphate pesticide, diazinon. 
  • Persistent infection with neurotropic herpes viruses and cognitive impairment. 
  • Persistent mild cognitive impairment in geriatric depression. 
  • Personality Structure Among Centenarians: The Georgia Centenarian Study. 
  • Personality facets and all-cause mortality among Medicare patients aged 66 to 102 years: a follow-on study of Weiss and Costa (2005). 
  • Perspective-taking ability and its relationship to the social behavior of autistic children. 
  • Perspectives on depression, mild cognitive impairment, and cognitive decline. 
  • Pervasive olfactory impairment after bilateral limbic system destruction. 
  • Physical activity, vascular health, and cognitive impairment. 
  • Physical frailty in late-life depression is associated with deficits in speed-dependent executive functions. 
  • Placebo Response and Practice Effects in Schizophrenia Cognition Trials. 
  • Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. 
  • Polymorphic variation in the dopamine D4 receptor predicts delay discounting as a function of childhood socioeconomic status: evidence for differential susceptibility. 
  • Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. 
  • Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. 
  • Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study. 
  • Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly. 
  • Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. 
  • Potential human health effects associated with laboratory exposures to Pfiesteria piscicida. 
  • Practitioner review: the assessment of bipolar disorder in children and adolescents. 
  • Predicting and preventing adverse neurologic outcomes with cardiac surgery. 
  • Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. 
  • Predictors of cognitive decline after cardiac operation. 
  • Predictors of cognitive recovery after cardiac surgery. 
  • Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. 
  • Predictors of performance monitoring abilities following traumatic brain injury: the influence of negative affect and cognitive sequelae. 
  • Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. 
  • Prefrontal white matter lesions and prefrontal task impersistence in depressed and nondepressed elders. 
  • Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice. 
  • Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. 
  • Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. 
  • Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs. 
  • Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. 
  • Prenatal dexamethasone augments the neurobehavioral teratology of chlorpyrifos: significance for maternal stress and preterm labor. 
  • Preoperative gene expression may be associated with neurocognitive decline after cardiopulmonary bypass. 
  • Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass. 
  • Presence of and correction for interviewer error on an instrument assessing cognitive function of older adults. 
  • Prevalence and patterns of comorbid cognitive impairment in low vision rehabilitation for macular disease. 
  • Prevalence of cognitive impairment in Chinese: epidemiology of dementia in Singapore study. 
  • Prevalence of cognitive impairment without dementia in the United States. 
  • Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. 
  • Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. 
  • Preventing Alzheimer's disease and cognitive decline. 
  • Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. 
  • Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline. 
  • Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study. 
  • Profile of depressive symptoms in younger and older medical inpatients with major depression. 
  • Prognostic value of posteromedial cortex deactivation in mild cognitive impairment. 
  • Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. 
  • Progression of impairment in patients with vascular cognitive impairment without dementia. 
  • Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods. 
  • Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use. 
  • Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. 
  • Prospective randomized trial of normothermic versus hypothermic cardiopulmonary bypass on cognitive function after coronary artery bypass graft surgery. 
  • Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. 
  • Protecting the brain in coronary artery bypass graft surgery. 
  • Prototype formation in autism. 
  • Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. 
  • Psychiatric disorders. A rural/urban comparison. 
  • Psychiatric morbidity during the early phase of coronary care for myocardial infarction: association with cardiac diagnosis and outcome. 
  • Psychiatric sequelae of traumatic brain injury: a case report. 
  • Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. 
  • Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia. 
  • Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys. 
  • Psychophysiological mediators of caregiver stress and differential cognitive decline. 
  • Pyridoxine-dependent seizures and cognition in adulthood. 
  • Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia. 
  • Quality of life and physical activity associated to lower prevalence of depression in community-dwelling elderly subjects from Sao Paulo. 
  • Racial differences in cognitive decline in a sample of community-dwelling older adults: the mediating role of education and literacy. 
  • Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. 
  • Radiation dose-volume effects in the brain. 
  • Randomized trial of early developmental intervention on outcomes in children after birth asphyxia in developing countries. 
  • Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia. 
  • Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. 
  • Reaction time distribution analysis of neuropsychological performance in an ADHD sample. 
  • Reaffirmed limitations of meta-analytic methods in the study of mild traumatic brain injury: a response to Rohling et al. 
  • Recollection- and familiarity-based memory in healthy aging and amnestic mild cognitive impairment. 
  • Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. 
  • Recruitment of rural and cognitively impaired older adults for dental research. 
  • Reduced levels of human apoE4 protein in an animal model of cognitive impairment. 
  • Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study. 
  • Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. 
  • Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. 
  • Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. 
  • Relationship of cognition and psychopathology to functional impairment in schizophrenia. 
  • Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. 
  • Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. 
  • Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. 
  • Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. 
  • Religious attendance reduces cognitive decline among older women with high levels of depressive symptoms. 
  • Religious coping and cognitive symptoms of depression in elderly medical patients. 
  • Religiousness affects mental health, pain and quality of life in older people in an outpatient rehabilitation setting. 
  • Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. 
  • Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. 
  • Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. 
  • Resolving postoperative neuroinflammation and cognitive decline. 
  • Response inhibition predicts poor antidepressant treatment response in very old depressed patients. 
  • Response to letter regarding article, "Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery". 
  • Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. 
  • Retinal microvascular abnormalities and cognitive function in Latino adults in Los Angeles. 
  • Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular signs and cognitive impairment. 
  • Retinal vascular fractal dimension is associated with cognitive dysfunction. 
  • Revisiting cycloid psychosis: a case of an acute, transient and recurring psychotic disorder. 
  • Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. 
  • Risk Factors and Consequences of Cortical Thickness in an Asian Population. 
  • Risk factors for hip fracture in skilled nursing facilities: who should be evaluated? 
  • Role of interleukin-1beta in postoperative cognitive dysfunction. 
  • Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. 
  • Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial. 
  • Schizophrenia is a cognitive illness: time for a change in focus. 
  • Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome. 
  • Science and recovery in schizophrenia. 
  • Scoring nonresponse on the Mini-Mental State Examination. 
  • Screening for cognitive impairment: comparing the performance of four instruments in primary care. 
  • Screening for distress in patients with brain cancer using the NCCN's rapid screening measure. 
  • Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness-Reply. 
  • Self-recognition in autistic children. 
  • Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis. 
  • Sensitivity of the dementia rating scale in vascular dementia: comparison between two sets of criteria to define cognitive impairment. 
  • Sensory acuity and reasoning in delusional disorder. 
  • Separating mood disturbance from mild cognitive impairment in geriatric depression. 
  • Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. 
  • Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. 
  • Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. 
  • Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. 
  • Shortness of breath as a predictor of depressive symptoms in a community sample of older adults. 
  • Sickle cell disease. 
  • Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention? 
  • Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. 
  • Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. 
  • Single-suture craniosynostosis: a review of neurobehavioral research and theory. 
  • Sluggish cognitive tempo in survivors of pediatric brain tumors. 
  • Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. 
  • Social functioning and facial expression recognition in children with neurofibromatosis type 1. 
  • Social functioning and facial expression recognition in survivors of pediatric brain tumors. 
  • Social-cognitive, physiological, and neural mechanisms underlying emotion regulation impairments: understanding anxiety in autism spectrum disorder. 
  • Socioeconomic status and psychological function in children with chromosome 22q11.2 deletion syndrome: implications for genetic counseling. 
  • Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications. 
  • Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. 
  • Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care Population. 
  • Stakeholders' perspective on issues and challenges associated with care and treatment of aging-related cognitive impairment disorders in Singapore. 
  • Standardizing the use of the Continuous Performance Test in schizophrenia research: a validation study. 
  • State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. 
  • Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. 
  • Statins and cognition: what can we learn from existing randomized trials? 
  • Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice. 
  • Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study. 
  • Subcortical Atrophy in Cognitive Impairment and Dementia. 
  • Subcortical white matter lesions and functional impairment in geriatric depression. 
  • Subjective memory beliefs and cognitive performance in normal and mildly impaired older adults. 
  • Subtypes of social withdrawal in early childhood: sociometric status and social-cognitive differences across four years. 
  • Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. 
  • Surgery results in exaggerated and persistent cognitive decline in a rat model of the Metabolic Syndrome. 
  • Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats. 
  • Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. 
  • Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. 
  • Targeting anemia in patients with lung cancer. 
  • The Aging, Demographics, and Memory Study: study design and methods. 
  • The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease. 
  • The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. 
  • The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition. 
  • The G72/G30 gene complex and cognitive abnormalities in schizophrenia. 
  • The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. 
  • The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective. 
  • The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. 
  • The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. 
  • The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. 
  • The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES). 
  • The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. 
  • The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. 
  • The association of age and depression among the elderly: an epidemiologic exploration. 
  • The association of depression and mortality in elderly persons: a case for multiple, independent pathways. 
  • The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. 
  • The combined effect of visual impairment and cognitive impairment on disability in older people. 
  • The continuous performance test, identical pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore. 
  • The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. 
  • The effect of cognitive functioning on treatment attendance and adherence in comorbid bipolar disorder and cocaine dependence. 
  • The effect of comorbid illness on receipt of cancer screening by older people. 
  • The effect of poststroke cognitive impairment on rehabilitation process and functional outcome. 
  • The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. 
  • The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. 
  • The expression of adult ADHD symptoms in daily life: an application of experience sampling methodology. 
  • The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. 
  • The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. 
  • The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. 
  • The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. 
  • The influence of depression on cognitive decline in community-dwelling elderly persons. 
  • The influence of lifetime depression on self-reported memory and cognitive problems: results from the National Comorbidity Survey-Replication. 
  • The influence of maternal stress and distress on disruptive behavior problems in boys. 
  • The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness. 
  • The moderating role of personality factors in the relationship between depression and neuropsychological functioning among older adults. 
  • The neural circuitry mediating shifts in behavioral response and cognitive set in autism. 
  • The neural circuitry of autism. 
  • The neuropsychological profile of vascular cognitive impairment--no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. 
  • The perspective of the person with Alzheimer disease: which outcomes matter in early to middle stages of dementia? 
  • The psychobiology of neglect. 
  • The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. 
  • The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. 
  • The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. 
  • The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. 
  • The vascular depression subtype: evidence of internal validity. 
  • Thought-control difficulty motivates structure seeking. 
  • Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. 
  • Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. 
  • Toward a new frontier in cardiac surgery. 
  • Transcerebral platelet activation after aortic cross-clamp release is linked to neurocognitive decline. 
  • Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. 
  • Transcription factor p53 influences microglial activation phenotype. 
  • Transcriptional control of cognitive development. 
  • Translational development strategy for magnetic seizure therapy. 
  • Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly. 
  • Treating cognitive deficits in multiple sclerosis: are we there yet? 
  • Treatment course with antidepressant therapy in late-life depression. 
  • Treatment efficacy: cognitive-communicative disorders resulting from traumatic brain injury in adults. 
  • Tuberous sclerosis complex and epilepsy: prognostic significance of electroencephalography and magnetic resonance imaging. 
  • Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. 
  • Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. 
  • Understanding cognition in older patients with cancer. 
  • Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials. 
  • Understanding symbol coding in schizophrenia. 
  • Understanding the nature of face processing impairment in autism: insights from behavioral and electrophysiological studies. 
  • Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia. 
  • Use of cardiac implantable electronic devices in older adults with cognitive impairment. 
  • Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease. 
  • Validation of the coin rotation test: a simple, inexpensive, and convenient screening tool for impaired psychomotor processing speed. 
  • Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia). 
  • Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. 
  • Variation in early developmental course in autism and its relation with behavioral outcome at 3-4 years of age. 
  • Vascular dementia: atherosclerosis, cognition and Alzheimer's disease. 
  • Vascular risk factors and cognitive decline among elderly male twins. 
  • Visual evoked potentials and visual processing in stimulant drug-exposed infants. 
  • Visual impairment, age-related eye diseases, and cognitive function: the Singapore Malay Eye study. 
  • Vitamin D Levels and the Risk of Cognitive Decline in Chinese Elderly People: the Chinese Longitudinal Healthy Longevity Survey. 
  • Vitamin D insufficiency and cognitive impairment in Asians: a multi-ethnic population-based study and meta-analysis. 
  • When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. 
  • Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. 
  • Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. 
  • α7-Nicotinic receptors and cognition. 
  • α7-Nicotinic receptors and cognition. 
• 

  Keywords of People

  • Barfield, Raymond Carlton, Professor of Pediatrics, Duke Science & Society
  • Berger, Miles, Assistant Professor of Anesthesiology, Duke Science & Society
  • Cabeza, Roberto, Professor of Psychology and Neuroscience, Duke Science & Society
  • Charles, Hal Cecil, Associate Professor of Radiology, Radiology
  • Chen, Nan-kuei, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Cunningham, Coleen Kathryn, Professor of Pediatrics, Pathology
  • Ferguson, P. Lee, Associate Professor of Civil and Environmental Engineering, Civil and Environmental Engineering
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Innovation & Entrepreneurship
  • LeBlanc, Thomas William, Associate Professor of Medicine, Duke Cancer Institute
  • MacFall, James R., Adjunct Professor in the Department of Radiology, Radiology
  • McClintock, Shawn Michael, Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Brain Stimulation and Neurophysiology
  • McConnell, Eleanor Schildwachter, Associate Professor in the School of Nursing, with tenure, School of Nursing
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Turkington, Timothy Garvey, Associate Professor in Radiology, Radiology
  • Zafar, Syed Yousuf, Associate Professor of Medicine, Medicine, Medical Oncology